Maze Therapeutics, Inc. (MAZE) stock
MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$34.33−1.76 (-4.88%)
Close on Nov 13, 2026Market cap $1.91BP/E –Yield –
Maze Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Maze Therapeutics's enterprise value was $1.67B on Nov 11, 2026, against $1.43B a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.67B | +3.6% |
| 2025 | Dec 31, 2025 | $1.61B | – |
See a number that looks wrong?